Project Grant HT9425261E197

Summary of Federal Cooperative Agreement Award The National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) awarded a Cooperative Agreement totaling $21.2 million to the University of Cincinnati's Sponsored Research Services Division, effective August 15, 2025, through May 31, 2032. The Center for Clinical and Translational Science and Training (CCTST)—a partnership between the University of Cincinnati and Cincinnati Children's Hospital Medical Center—will transform its clinical...

Summary of Cooperative Agreement Award The National Center for Advancing Translational Sciences (NCATS), under CFDA 93.350, awarded the University of California, Davis a $5.76 million Cooperative Agreement beginning June 1, 2026, and extending through May 31, 2033, to establish and operate the UC Davis Clinical and Translational Science Center (CTSC). The CTSC will deliver clinical and translational science (CTS) infrastructure, expertise, and support services designed to accelerate the...

Federal Project Grant Award Summary The University of Cincinnati's Center for Clinical and Translational Science and Training (CCTST) received a $1.82 million Project Grant from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) awarded August 17, 2025, with completion scheduled for May 31, 2030. This award supports the CTSA K12 Scholars Program, which transitions from a previous KL2 mechanism to advance training in translational science. The program will recruit and...

Federal Cooperative Agreement Summary Duke University's Office of Research Administration was awarded a Clinical and Translational Science Award (CTSA) Cooperative Agreement from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) in the amount of $19.78 million, effective August 15, 2025, through July 31, 2032. The Duke Clinical and Translational Science Institute will catalyze translational science through five primary service areas: (1) advancing clinical and...

Federal Cooperative Agreement Award Summary The National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) awarded a Cooperative Agreement totaling $622,077 to The Johns Hopkins University, with an award date of September 15, 2025, and completion date of June 30, 2030. The award funds the IMPACT Study (Initiation of a cohort to define pathogenic Mechanisms, Precision diagnosis And Complications of Thrombotic Microangiopathies), which establishes a Rare Disease Clinical Research...

Federal Cooperative Agreement Summary Award: New York University Clinical and Translational Science Hub Funding Agency: National Center for Advancing Translational Sciences (NCATS) Program: NCATS (CFDA 93.350) Award Amount: $19.16M Award Date: March 20, 2026 Completion Date: December 31, 2032 New York University's Clinical and Translational Science Institute (CTSI) will establish and operate a clinical and translational science hub over the seven-year funding period through this Cooperative...

The University of Rochester received a $223,364 Project Grant award dated September 12, 2025, from the National Center for Advancing Translational Sciences (NCATS) under the Clinical and Translational Science Award (CFDA 93.350) program to support its Clinical and Translational Science Institute (CTSI) T32 Predoctoral Training Program. This five-year award, with an ultimate completion date of August 31, 2030, funds a comprehensive mentored research training initiative designed to cultivate the...

Federal Cooperative Agreement Summary Weill Medical College of Cornell University received a $3.25 million Cooperative Agreement from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) for the period April 1, 2026 through March 31, 2028. The award supports a Phase 1A clinical trial investigating the safety and tolerability of a novel gene therapy treatment for Apolipoprotein E4 (APOE4) homozygous Alzheimer's disease. The primary deliverable is the execution of a...

Federal Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $489,500 Project Grant award from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) effective June 5, 2025, through May 31, 2027. The award funds research and development activities focused on translating the compound REPSOX and its analogs toward clinical application as a prophylactic intervention for Familial Platelet Disorder with Associated Myeloid Malignancy (FPDMM),...

Federal Grant Award Summary CTSA K12 Program at New York University New York University School of Medicine received a $3.14 million Project Grant from the National Center for Advancing Translational Sciences (NCATS) under CFDA 93.350, awarded April 15, 2026, with a completion date of January 14, 2031. The grant funds the Clinical Translational Science Institute (CTSI) K12 Program, which trains the next generation of clinical and translational researchers to conduct rigorous, reproducible, and...